Fri, Nov 28, 2014, 10:55 AM EST - U.S. Markets close early today in 2 hrs 5 mins for The day after Thanksgiving

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

Title   Replies Latest Post

NEWS COMING - BUYOUT?

Oct 10, 2014 3:56 PM by hairynutzcapital
0/1 6 Oct 10, 2014 7:08 PM by snowflakeformationxy

Sell NOW! This bloated pig is getting ready to take another plunge and stiff investors onc...

Oct 6, 2014 11:03 AM by semanresu
1/3 6 Oct 6, 2014 2:28 PM by socialidiocies

Stifel Nicholas comments:

Sep 2, 2014 12:34 PM by enabeler
2/0 6 Sep 2, 2014 4:56 PM by urabt2

Anadys, Papadopoulos, Roche and Exelixis.

Sep 15, 2014 3:50 PM by enabeler
2/1 6 Sep 16, 2014 4:04 PM by valleyofloire

A Novel TKI Targeted Agent... Cabozantinib

Sep 4, 2014 1:04 PM by wilderguide
7/6 6 Sep 5, 2014 11:01 AM by mruyog

Cometriq approval for prostate = 40% compound revenue growth X 5 years

Aug 29, 2014 1:32 PM by cthekingdom
6/8 6 Aug 29, 2014 10:06 PM by socialidiocies

This IS NOT The End

Sep 2, 2014 11:40 AM by mruyog
0/0 6 Sep 2, 2014 3:05 PM by mruyog

JTO November 2014

Nov 7, 2014 8:34 PM by wilderguide
4/1 6 Nov 8, 2014 5:20 PM by wilderguide

EMSO time is drawing near. Embargo and Publication schedule for accepted abstracts

Sep 12, 2014 3:27 PM by clemcaldwell
1/1 6 Sep 12, 2014 5:38 PM by semanresu

Cobimetinib

Oct 19, 2014 9:17 AM by franca_ole
3/2 6 Oct 21, 2014 2:02 PM by franca_ole

No Increase in Survival Duration, But..

Sep 1, 2014 7:04 PM by w_prtt
0/1 6 Sep 1, 2014 9:02 PM by kcbs2

you can look at GSK most recent quarter and see sales of

Oct 25, 2014 11:29 AM by zoomlik
2/0 6 Oct 25, 2014 4:38 PM by semanresu

After Hours

Oct 14, 2014 4:47 PM by laxfreak212
0/2 6 Oct 15, 2014 4:26 PM by hlew57s

glad to see some volume today

Nov 5, 2014 10:50 AM by alsodoglover
0/1 6 Nov 5, 2014 1:23 PM by mj525252

EXAM OS, wild-type EGFR NSCLC, and XL-888

Nov 4, 2014 5:42 PM by wilderguide
5/1 6 Nov 5, 2014 5:16 PM by alexp1112

Pending bids!

Nov 13, 2014 10:29 AM by godhairyballs
0/3 6 Nov 13, 2014 1:38 PM by pricetodilute

OT - I know you die hard EXEL fanatics don't like this but....

Nov 25, 2014 12:34 PM by semanresu
0/0 6 Nov 25, 2014 2:47 PM by mkt_con

Merck wins breakthrough FDA approval for blockbuster cancer contender pembrolizumab Septem...

Sep 17, 2014 3:03 PM by clemcaldwell
4/0 5 Sep 17, 2014 11:48 PM by neers87

free fall

Sep 16, 2014 12:42 PM by drscottpalmer
2/2 5 Sep 16, 2014 1:40 PM by socialidiocies

Promotion & Performance Options

Sep 26, 2014 3:59 PM by nesoccr
2/0 5 Sep 26, 2014 7:24 PM by gabrjelac

Help Us Make it Better!

We are in the process of testing our new message boards.
Please provide your feedback so that we can optimize the user experience.

Go
EXEL
1.760.00(0.00%)10:54 AMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.